January 20, 2010
This week UMR released a detailed report on how Recovery Act funding of medical research through the National Institutes of Health (NIH) is at work across the country in the service of better health and a healthier economy.
Investing in Recovery and Discovery documents how the $10.5 billion infusion in 2009 and 2010 in biomedical innovation is creating jobs, fueling industry growth, and helping reduce long-term health care costs.
The report illustrates these benefits of the Recovery Act funding through real-life stories of scientists and their work. It also notes that many such scientific and economic advancements could be slowed or neglected if funding were to fall back to pre-Recovery Act levels in 2011 and beyond.
As Janet Lambert of UMR’s Executive Board states, “the stimulus infusion is demonstrating that reinvesting in innovative biomedical ideas through the NIH can help the nation achieve better health and a stronger economy. How much we commit to NIH over time in large measure will determine our success.”